Crossmark

Current status and perspectives of clinical trials for tumor-infiltrating lymphocyte therapy

Crossref DOI link: https://doi.org/10.1007/s12094-024-03608-z

Published Online: 2024-07-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Yunting

Fu, Hongye

Zhao, Qiong https://orcid.org/0009-0004-9594-0093
License Information

Text and Data Mining valid from 2024-07-30

Version of Record valid from 2024-07-30
More Information

Article History

Received: 3 April 2024

Accepted: 9 July 2024

First Online: 30 July 2024

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.